Top Markets
#1 Siren Siren +36.83%
#2 Wiki Cat Wiki Cat +27.76%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.44%
#4 Gnosis Gnosis +22.36%
#5 Bridged Wrapped stETH (Gnosis) Bridged Wrapped stETH (Gnosis) +21.58%
#6 Velvet Velvet +19.46%
#7 The Grays Currency The Grays Currency +17.02%
#8 PulseChain PulseChain +16.72%
#9 Janction Janction +16.09%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.88%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Organicell Regenerative Medicine, Inc. Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

OCEL
Classifica tra le azioni #31534
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical... Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.
Prezzo delle azioni
$1.77
Ultima sincronizzazione: 2024-04-02
Capitalizzazione di mercato
$12.89M
Variazione (1 giorno)
-11.50%
Variazione (1 anno)
0.00%
Paese
US
Scambia Organicell Regenerative Medicine, Inc. (OCEL)

Categoria

Healthcare
Utile per Organicell Regenerative Medicine, Inc. (OCEL)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Organicell Regenerative Medicine, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Organicell Regenerative Medicine, Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE